PRACTITIONER FINAL PRACTICE TEST
2026 ALL SECTIONS COVERED QUESTIONS
WITH CORRECT ANSWERS 100 PERCENT
CORRECT GRADED A+
⩥ Mr. Smith is a 56 year old white male who has been successfully
treated on Selegiline for over 4 years. Mr. Smith is going in for elective
surgical procedure. Which medication is strictly contraindicated with
Selegiline?
A) Non-steroidal anti-inflammatory drugs (NSAIDS)
B) Codeine
C) Morphine
D) Meperidine. Answer: D) Meperidine is strictly prohibited when a
patient is treated on a monoamine oxidase inhibitor (MAOI) due to the
risk of hypertensive crisis and death.
⩥ A WBC of 4,000 in a patient taking Clozapine would prompt the
PMHNP to take which of the following actions?
A) Consult with hematologist to determine appropriate antibiotic
regimen and monitor closely.
, B) Institute twice-weekly complete blood count with differentials and
monitor closely.
C) Discontinue clozapine, initiate alternative antipsychotic medication
and monitor closely.
D) Institute daily complete blood count with differentials and monitor
closely.. Answer: B) Institute twice-weekly complete blood count with
differentials and monitor closely.
The recommended cut-points for discontinuation of clozapine are WBC
of 2,000 to 3,000 or granulocytes of 1,000 to 1,500 for agranulocytosis
and severely compromised immune system. At a WBC of 4,000, the
recommendation is to closely monitor CBC with differential twice a
week while patient may continue clozapine in the absence of any other
signs or symptoms.
⩥ A patient with a diagnosis of schizophrenia has a history of suicidal
ideation and suicide attempts. The PMHNP should consider which
antipsychotic medication that is the only antipsychotic to reduce the risk
of suicide in schizophrenia?
A) Abilify (aripriprazole)
B) Latuda (lurasidone)
C) Invega (iloperidone)
D) Clozaril (clozapine). Answer: D) Clozaril (clozapine) is the only
known antipsychotic medication that had been shown to reduce the risk
of suicide in patients diagnosed with schizophrenia.